Chemical Structure : NX-13
CAS No.: 2389235-01-0
货号: PC-49115Not For Human Use, Lab Use Only.
NX-13 (Amelenodor) is an orally active, gut-restricted NLRX1 agonist, has in situ binding effects on the stability of NLRX1 with EC50 of 58 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1980 | In stock | |
10 mg | ¥2980 | In stock | |
25 mg | ¥4880 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NX-13 (Amelenodor) is an orally active, gut-restricted NLRX1 agonist, has in situ binding effects on the stability of NLRX1 with EC50 of 58 nM.
NX-13 modulates CD4+ T cell differentiation and metabolism, NX-13 significantly decreased the differentiation of Th1 and Th17 at 0.05 μM with a dose response and suppressive effect down to 0.005 μM.
NX-13 (10 mg/kg, oral) reduces inflammation in a model of DSS colitis.
NX-13 reduces inflammation and alters NLRX1 signaling in PBMCs from ulcerative colitis (UC) patients, decreases NF-κB activity, TNFα+ and IFNγ+ CD4+ T cells and overall production of IL-6, MCP1 and IL-8.
NX-13 is a promising immunometabolic oral, gut-restricted therapeutic for CD and UC that is effective at reducing inflammation in DSS, adoptive transfer and Mdr1a−/− mouse models of IBD plus in in vitro studies using primary murine and human cells.
NLRX1 (Nucleotide-binding oligomerization domain, leucine rich repeat containing X1) is a mitochondria-associated receptor involved in down-regulating inflammation during bacterial and viral exposure, acute non-infectious colitis, colorectal cancer and chronic pulmonary disease.
分子量 | 399.450 | |
分子式 | C24H21N3O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1,3,5-tris (6-methylpyridin-2-yloxy) benzene |
1. Leber A, et al. J Immunol. 2019 Dec 15;203(12):3407-3415.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright